Discover how platelet biomarkers reveal hidden immune responses in VAD patients and revolutionize personalized cardiac care.
Discover how the neutrophil-to-lymphocyte ratio (NLR), a simple blood test, predicts survival outcomes in glioblastoma patients and guides personalized treatment strategies.
Discover how the Cyr61 protein blood test can predict long-term recovery outcomes for heart attack survivors, enabling personalized treatment and better care.
Discover how PDK4, a metabolic regulator, emerges as a potential biomarker for rheumatoid arthritis diagnosis and treatment through cutting-edge research.
Discover how Syndecan-1, a tiny molecule from the glycocalyx, serves as a powerful biomarker for predicting heart failure and chronic liver disease progression.
Discover how the PTGDR2 gene expression in blood could revolutionize asthma diagnosis and personalized treatment approaches.
Discover how the Melanoma Inflammation Index (MII) uses simple blood tests to predict immunotherapy success in melanoma patients, potentially revolutionizing treatment approaches.
Discover how Thioredoxin, a powerful antioxidant protein, serves as a critical biomarker for predicting survival and neurological outcomes in patients after cardiac arrest.